View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Vasculitis and Giant Cell Arteritis News

SPONSORED CONTENT
Save
SPONSORED CONTENT
May 29, 2020
6 min read
Save

Breathing 'Rheum' in COVID-19 Hotspots: Detroit juggles poverty, protests, and possible resurgence

Breathing 'Rheum' in COVID-19 Hotspots: Detroit juggles poverty, protests, and possible resurgence

The COVID-19 pandemic, in places like Detroit, with a large working-class population, can highlight the gap between the rich and the poor. It can demonstrate how political unrest can impact the response to a critical situation. Moreover, it can show how health care workers can face both personal and professional challenges in managing an outbreak of this magnitude.

SPONSORED CONTENT
May 04, 2020
3 min read
Save

EULAR: Rheumatologist, oncologist collaboration 'pivotal' to enhance checkpoint inhibitor management

EULAR: Rheumatologist, oncologist collaboration 'pivotal' to enhance checkpoint inhibitor management

Oncologists should be encouraged to promptly consult with rheumatologists in the event of suspected immune-related adverse events due to checkpoint inhibitor therapy, according to a series of “points to consider” published by EULAR in the Annals of the Rheumatic Diseases.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
April 24, 2020
6 min read
Save

Breathing 'Rheum' in COVID-19 Hotspots: New Orleans finds new 'camaraderie' amid economic bust

Breathing 'Rheum' in COVID-19 Hotspots: New Orleans finds new 'camaraderie' amid economic bust

The very idea of social distancing runs contrary to congregation and celebration, two things that lie at the core of New Orleans culture. It is for this reason, perhaps, that New Orleanians were initially resistant to quarantine measures to contain COVID-19. But as the death toll climbed and Mayor LaToya Cantrell canceled St. Patrick’s Day festivities, the city slowly awakened to the idea that this was serious business.

SPONSORED CONTENT
April 23, 2020
38 min listen
Save

The History of Cryoglobulinemic Vasculitis: Dry Humors, Part 3

The History of Cryoglobulinemic Vasculitis: Dry Humors, Part 3

This episode explores the history of cryoglobulinemic vasculitis, from the first person who froze a tube of blood and noticed something strange happened, to the discovery of hepatitis C. We also throw in how the lab test for cryoglobulins is performed and some of the data we have on therapy.

SPONSORED CONTENT
April 20, 2020
2 min read
Save

Cigarette smoking increases risk for ANCA-associated vasculitis

Cigarette smoking increases risk for ANCA-associated vasculitis

Cigarette smoking was associated with ANCA-associated vasculitis, particularly myeloperoxidase ANCA-positive vasculitis, according to data published in JAMA Internal Medicine.

SPONSORED CONTENT
April 08, 2020
54 min listen
Save

Dry Humors, Part 2

Dry Humors, Part 2

In Part 2, I sit down with nephrologist Ali Mehdi, MD, and neurologist Ghulam Abbas Kharal, MD, MPH, to discuss their different specialty perspectives on working up patients with suspected cryoglobulinemic vasculitis.

SPONSORED CONTENT
March 27, 2020
38 min listen
Save

Dry Humors, Part 1

Dry Humors, Part 1

Try your hand at this medical mystery, which is followed by some didactics on a fascinating disease which will hopefully make sense of this inscrutable title.

SPONSORED CONTENT
March 26, 2020
3 min read
Save

Rheumatology coalition unveils patient registry to 'curate, disseminate' COVID-19 data

Rheumatology coalition unveils patient registry to 'curate, disseminate' COVID-19 data

A newly formed organization, the COVID-19 Global Rheumatology Alliance, has launched an international registry to collect data on patients with rheumatic diseases who may or may not have contracted the infection that is causing the global pandemic. The aim is to aid clinicians and researchers in real time as the situation evolves.

SPONSORED CONTENT
March 16, 2020
2 min read
Save

Adalimumab trials show low rate of IBD adverse events

Adalimumab trials show low rate of IBD adverse events

A review of 75 adalimumab clinical trials in adult and pediatric patients demonstrated low rates of inflammatory bowel disease adverse events, according to data published in Arthritis Care & Research.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails